me too honestly, I've been reluctant to buy because of valtorcitabine and what looked like a sure bet for lowering 07 guidance on tyzeka..if ex-US is going better and they even come close - say 15M even - then i think more than a few analysts will be surprised
i still think not much though is going to happen until HIV results are released 2/08, although now that telbivudine seems to be selling abroad i don't see how the stock can go down either
PS: i place the odds of successful 1b/2a for 899 at 88.5% (DD - that one was for you)